Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer

Clinical trial NCT02568839 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02568839
Sponsor: Thomas Hatschek
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Early-Stage Breast Carcinoma HER-2 Positive Breast Cancer

Start date: 2014-11-01
Primary completion: 2019-02-01
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.